PAHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Phibro Animal Health Corp (PAHC) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company demonstrates strong financial performance, bullish technical indicators, and raised guidance, making it a solid long-term investment opportunity.
The technical indicators are bullish. The MACD is positive and contracting, suggesting momentum is still upward. The RSI is neutral at 68.982, and the moving averages (SMA_5 > SMA_20 > SMA_200) confirm a bullish trend. Key resistance levels are at R1: 55.403 and R2: 58.502, while support levels are at S1: 45.372 and S2: 42.273.
Raised FY26 guidance, margin expansion, and a Q2 earnings beat. Revenue grew 20.90% YoY, and net income surged 762.14% YoY, indicating strong operational performance. Analysts have raised the price target from $45 to $49.
Insider selling has increased significantly by 342.13% over the last month, which may indicate a lack of confidence from insiders. Additionally, hedge funds remain neutral, and there is no recent news to act as a catalyst.
In Q2 2026, revenue increased by 20.90% YoY to $373.91M. Net income grew by 762.14% YoY to $27.459M, and EPS rose by 737.50% YoY to 0.67. Gross margin improved to 35.7%, up 6.66% YoY, showcasing robust financial growth and operational efficiency.
Morgan Stanley raised the price target from $45 to $49, maintaining an Equal Weight rating. Analysts highlight strong execution in the Animal Health segment and cost management as key drivers of the company's performance.
